Satsuma Pharmaceuticals Inc (STSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2006 | 12-2005 | 09-2005 | 06-2005 | 03-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 15,416 | 61,219 | 45,789 | 31,899 | 15,891 |
| Depreciation Amortization | 4,586 | 20,063 | 14,805 | 9,133 | 3,991 |
| Income taxes - deferred | N/A | -6,212 | N/A | N/A | N/A |
| Other Working Capital | 5,332 | 13,067 | 2,350 | 12,608 | 4,923 |
| Loans | 0 | -6,399 | -6,399 | -6,399 | -3,232 |
| Other Operating Activity | 5,475 | 20,571 | -172 | -3,317 | -9,780 |
| Operating Cash Flow | $30,809 | $102,309 | $56,373 | $43,924 | $11,793 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,587 | -12,633 | -8,817 | -6,165 | -2,531 |
| Purchase Of Investment | -12,359 | -488,867 | -216,921 | -158,952 | -158,369 |
| Sale Of Investment | 68,675 | 518,411 | 424,297 | 312,355 | 216,610 |
| Net Loans | -375,419 | -640,858 | -56,173 | 66,204 | -128,074 |
| Other Investing Activity | 37 | -5,808 | -13,820 | -1,877 | 945 |
| Investing Cash Flow | $-322,653 | $-629,755 | $128,566 | $211,565 | $-71,419 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 68,744 | -168,336 | -318,418 | -243,860 | -35,132 |
| Debt Issued | 573,747 | 1,204,777 | 530,229 | 425,229 | 320,229 |
| Debt Repayment | -646,036 | -1,395,513 | -881,710 | -726,515 | -428,596 |
| Common Stock Issued | 2,838 | 3,411 | 2,781 | 1,968 | 1,509 |
| Dividend Paid | -1,917 | -1,736 | N/A | N/A | N/A |
| Other Financing Activity | 915 | -20,042 | -18,643 | -19,549 | -12,541 |
| Financing Cash Flow | $277,292 | $565,566 | $-158,300 | $-225,827 | $90,483 |
| Beginning Cash Position | 131,307 | 93,187 | 93,187 | 93,187 | 93,187 |
| End Cash Position | 116,755 | 131,307 | 119,826 | 122,849 | 124,044 |
| Net Cash Flow | $-14,552 | $38,120 | $26,639 | $29,662 | $30,857 |
| Free Cash Flow | |||||
| Operating Cash Flow | 30,809 | 102,309 | 56,373 | 43,924 | 11,793 |
| Capital Expenditure | -3,664 | -12,901 | -9,066 | -6,414 | -2,780 |
| Free Cash Flow | 27,145 | 89,408 | 47,307 | 37,510 | 9,013 |